Cargando…
Sulodexide therapy for the treatment of diabetic nephropathy, a meta-analysis and literature review
Sulodexide is a heterogeneous group of sulfated glycosaminoglycans (GAGs) that is mainly composed of low-molecular-weight heparin. Clinical studies have demonstrated that sulodexide is capable of reducing urinary albumin excretion rates in patients with type 1 and type 2 diabetes, suggesting that su...
Autores principales: | Li, Rui, Xing, Jing, Mu, Xaojing, Wang, Hui, Zhang, Lei, Zhao, Yu, Zhang, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671764/ https://www.ncbi.nlm.nih.gov/pubmed/26664049 http://dx.doi.org/10.2147/DDDT.S87973 |
Ejemplares similares
-
Sulodexide in IgA nephropathy
Publicado: (2013) -
Anti-Proteinuric Effect of Sulodexide in Immunoglobulin A Nephropathy
por: Bang, Kitae, et al.
Publicado: (2011) -
Effect of sulodexide in patients with non-proliferative diabetic retinopathy: diabetic retinopathy sulodexide study (DRESS)
por: Song, Ji Hun, et al.
Publicado: (2014) -
Sulodexide for Diabetic-Induced Disabilities: A Systematic Review and Meta-Analysis
por: Bignamini, Angelo A., et al.
Publicado: (2021) -
The renoprotective effects of sulodexide
por: Olde Engberink, Rik HG, et al.
Publicado: (2016)